20
Francopia Paris Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
One of their significant offerings is Naltrexone hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2009-287 - Rev 03
This Chemical Type CEP, issued on March 01, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1790 associated with this CEP further emphasizes